STRYKER CORP Current State and Local Tax Expense (Benefit)
STRYKER CORP (SYK) reported Current State and Local Tax Expense (Benefit) of $149.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-11
- STRYKER CORP current state and local tax expense (benefit) for fiscal 2025 was $149.00M, a 65.56% increase from fiscal 2024.
- STRYKER CORP current state and local tax expense (benefit) for fiscal 2024 was $90.00M, a 87.50% increase from fiscal 2023.
- STRYKER CORP current state and local tax expense (benefit) for fiscal 2023 was $48.00M, a 25.00% decline from fiscal 2022.
- STRYKER CORP current state and local tax expense (benefit) for fiscal 2022 was $64.00M, a 34.02% decline from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $149.00M 10-K · filed 2026-02-11 | |
| 2024-12-31 | $90.00M 10-K · filed 2026-02-11 | |
| 2023-12-31 | $48.00M 10-K · filed 2026-02-11 | |
| 2022-12-31 | $64.00M 10-K · filed 2025-02-12 | |
| 2021-12-31 | $97.00M 10-K · filed 2024-02-14 | |
| 2020-12-31 | $20.00M 10-K · filed 2023-02-10 | |
| 2019-12-31 | $46.00M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $30.00M 10-K · filed 2021-02-11 | |
| 2017-12-31 | $38.00M 10-K · filed 2020-02-06 | |
| 2016-12-31 | $50.00M 10-K · filed 2019-02-07 | |
| 2015-12-31 | $23.00M 10-K · filed 2018-02-08 | |
| 2014-12-31 | $26.00M 10-K · filed 2017-02-09 | |
| 2013-12-31 | $29.00M 10-K · filed 2016-02-11 | |
| 2012-12-31 | $41.00M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $33.00M 10-K · filed 2014-02-13 | |
| 2010-12-31 | $21.00M 10-K · filed 2013-02-27 | $21.20M 10-K · filed 2011-02-18 |
| 2009-12-31 | $27.00M 10-K · filed 2012-02-13 | $26.60M 10-K · filed 2011-02-18 |
| 2008-12-31 | $48.10M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |